Adipose tissue is now recognised as a highly active metabolic and endocrine organ. Great strides have been made in uncovering the multiple functions of the adipocyte in cellular and molecular detail, but it is essential to remember that adipose tissue normally operates as a structured whole. Its functions are regulated by multiple external influences such as autonomic nervous system activity, the rate of blood flow and the delivery of a complex mix of substrates and hormones in the plasma. Attempting to understand how all these factors converge and regulate adipose tissue function is a prime example of integrative physiology. Adipose tissue metabolism is extremely dynamic, and the supply of and removal of substrates in the blood is acutely regulated according to the nutritional state. Adipose tissue possesses the ability to a very large extent to modulate its own metabolic activities, including differentiation of new adipocytes and production of blood vessels as necessary to accommodate increasing fat stores. At the same time, adipocytes signal to other tissues to regulate their energy metabolism in accordance with the body's nutritional state. Ultimately adipocyte fat stores have to match the body's overall surplus or deficit of energy. This implies the existence of one (or more) signal(s) to the adipose tissue that reflects the body's energy status, and points once again to the need for an integrative view of adipose tissue function.
Introduction
Over the past decade, remarkable strides have been made in recognising the complex nature of the adipocyte as a secretory cell as well as a site of the regulation of energy storage. Many informative studies have been performed with cultured adipocytes. However, there are some aspects of adipose tissue function that require a more integrative approach to their study. The regulation of adipose tissue metabolism in vivo, for instance, must involve the activity of the autonomic nervous system, the delivery of a complex mixture of substrates and hormones to adipose tissue in the plasma, feedback from autocrine and paracrine effectors secreted by adipocytes and also blood flow through adipose tissue. All of these influences are likely to change with time and nutritional state. In addition, factors such as leptin secreted by adipocytes may feed back to other bodily systems to regulate energy balance. It seems unlikely that cellular or molecular studies of adipocytes will ever be able to elucidate the multitude of factors that integrate to regulate adipocyte metabolism in vivo. Trying to understand the regulation of adipose tissue function is therefore a prime example of integrative physiology.
In this review we have attempted to illustrate the complexity of adipose tissue function, with an emphasis on the dynamic nature of this tissue. Our aim is not to duplicate the many excellent reviews that have been written recently about adipocytes, but rather to bring together those aspects of adipose tissue function that must interact in vivo for it to fulfil its biological functions. Thus, we will cover some aspects of the regulation of fat storage and mobilisation; the regulation of adipose tissue blood flow and the role of adipose tissue innervation; some aspects of the secretory functions of adipose tissue as they relate to regulation of fat balance; and finally, to demonstrate the integrative nature of adipose tissue function, possible oscillatory behaviour of the adipose tissue mass. Our review builds upon our joint experiences of studying human adipose tissue function in vivo.
Regulation of fat stores
The regulation of whole-body fat stores illustrates the complex nature of adipose tissue integrative physiology.
Glycogen stores are small in relation to energy throughput, and adipose tissue triacylglycerol (TG) is therefore the longterm repository for excess energy. The amount of TG stored within adipocytes must be an accurate reflection of the imbalance between energy intake and energy expenditure, integrated over a long period. The TG store of adipocytes in turn reflects the net balance between fat deposition and fat mobilisation. The pathways of fat storage and mobilisation in adipocytes are therefore regulated in accordance with whole-body energy balance. Recent studies demonstrate that this is indeed the case, and give insights into the mechanisms of this regulation.
The individual pathways of TG deposition and TG mobilisation and their regulation have been reviewed in detail elsewhere. [1] [2] [3] In human adipose tissue, the capacity for de novo lipogenesis (DNL) appears to be low, 4 and the contribution of DNL generally to metabolism appears not to be significant except perhaps under conditions of overfeeding with a high-carbohydrate diet. 5 There is one report that considerable whole-body DNL during carbohydrate overfeeding did not occur in the liver, suggesting adipose tissue as a likely site. 6 However, during normal, eucaloric conditions it seems that most of the TG deposited in adipose tissue arises from the pathway mediated by lipoprotein lipase (LPL)Fhydrolysis of circulating lipoprotein-TG, followed by uptake of the fatty acids, and esterification to glycerol 3-phosphate. Both the activities of adipose tissue LPL and the pathway of esterification are stimulated by insulin, [7] [8] [9] [10] leading to a very energy-efficient pathway for storage of dietary TG in the postprandial period. Increased adipose tissue blood flow (ATBF) in the postprandial period may also be involved, and is discussed below. Net fat storage must also be regulated on a site-specific basis by steroid hormones (glucocorticoids and sex steroids), reviewed below. Recently, a novel stimulator of the pathway of fat deposition has been identified, the 76-amino-acid peptide, acylation-stimulating protein (ASP). 11 ASP was initially recognised as an activity in plasma that stimulated fatty acid esterification in adipose tissue. 12 Later it was found to be identical to the peptide C3a-desarg, 11 a known product of the interaction of components B, C 3 and D of the alternative complement pathway. Component D had already been identified as a major protein expressed in adipocytes, initially called adipsin, and it had been recognised that all these three components were produced by adipocytes. 13 The production of ASP in vitro is stimulated by the presence of chylomicrons, 14 and its production by adipose tissue in vivo increases in the postprandial period, 15 giving ASP a potential role in coordination of postprandial fat storage. However, physiological importance in humans remains unclear at present. The pathway of fat mobilisation is exquisitely sensitive to suppression by insulin. The half-maximal insulin concentration for suppression of fat mobilisation in humans is around 90 pmol/l, 16 whereas that for glucose production is around 200 pmol/l. 17 When insulin is infused to moderately high physiological concentrations, there is therefore complete suppression of nonesterified fatty acid (NEFA) release from subcutaneous adipose tissue. 18 This is brought about by a dual action, inhibition of hormone-sensitive lipase (HSL) by dephosphorylation, and stimulation of the re-esterification of fatty acids by the pathway described earlier. Stimulation of fat mobilisation requires activation of HSL by phosphorylation, 3 and involves increased gene transcription in the longer term. 19 Phosphorylation of HSL by protein kinase A is accompanied by translocation of HSL from the adipocyte cytosol to the surface of the lipid droplet 20 and also by phosphorylation of perilipin, a protein that appears to coat the lipid droplet and to move away upon stimulation, to allow HSL access. 20 Acute activation of lipolysis, via perilipin and HSL phosphorylation, may be brought about by catecholamines acting through b-adrenergic receptors, although in the situation of overnight fasting, when lipolysis increases steadily, b-adrenergic stimulation appears not to be involved; 21 progressive removal of insulin inhibition may be more important. Overnight secretion of growth hormone 22 and the morning rise in cortisol 23 play additional modulatory roles. Atrial natriuretic peptide has been suggested 24 as an activator of HSL, but its physiological importance remains uncertain. These pathways have been further elucidated recently using data from human genetics and from genetic manipulations in animals. Clearly, fat deposition can still occur in the absence of LPL, because it has long been known that patients with complete LPL deficiency have relatively normal adipocytes. 25, 26 Mice lacking LPL specifically in adipose tissue have normal fat mass, but this is achieved by upregulation of de novo fatty acid synthesis. 27 Diacylglcyerol acyltransferase (DGAT) is the terminal enzyme in TG deposition whatever the source of the fatty acids. There are two isoforms of DGAT, DGAT1 and DGAT2, both expressed in white adipose tissue. Adipose tissue fat storage is reduced but not absent in mice deficient in DGAT1. 28 Energy balance in these mice is attained, despite an increase in energy intake, by an increase in energy expenditure. 28, 29 Murine adipocytes lacking HSL are enlarged. They display normal basal lipolytic activity, suggesting that other lipases may play a role, but catecholamine stimulation of lipolysis is severely reduced. 30, 31 Mice lacking perilipin are lean, but their adipocytes display elevated basal lipolysis and, again, impaired catecholamine stimulation. 32 These findings accord with the view that phosphorylation of both HSL and perilipin is important for catecholamine stimulated lipolysis. Neutral lipases present in the cell may take over the role of HSL in basal lipolysis, and may even to some extent be stimulated by catecholamines because 'access' to the fat droplet will be allowed when phosphorylated perilipin moves away. The aim of this brief description of the pathways of fat deposition and mobilisation, summarised in Figure 1 , is not to be comprehensive, but rather to show that a multiplicity of hormonal and neural influences may be involved. The adipocyte regulates how much fat it will store, partly through its own gene products. LPL in the adipose tissue capillaries, itself a product of adipocyte gene expression, generates a surplus of fatty acids, and the adipocyte takes up and esterifies a proportion of these: the remainder mix with NEFAs released from adipocyte lipolysis. 33 Production of ASP (an adipocyte-derived stimulator of fat storage) represents one way in which the adipocyte may regulate how much fat it takes up. The opposing pathway, lipolysis of adipocyte TG, is again a function of the adipocyte. In order to regulate how much fat to store and mobilise, the adipocyte must respond to signalling mechanisms. If fat storage is impaired, for instance in the situation of DGAT deficiency, then other pathways come into play to maintain energy balance (in that case, increased energy expenditure including an increase in physical activity 28 ). The integrative nature of adipose tissue physiology is apparent. While individual adipocytes may expand or contract by the pathways described in this section, at some point in the process of fat storage there is a need for more adipocytes. The differentiation of new adipocytes is regulated by many factors in common with the pathway of fat deposition.
Adipocyte differentiation
Preadipocytes, fibroblast-like cells present in the stromalvascular fraction of adipose tissue, can differentiate to form mature adipocytes and this capacity is present throughout life. 34 The topic of fat cell differentiation has been covered in detail elsewhere, [35] [36] [37] ) and particularly PPARg. The natural ligand for PPARg is probably a fatty acid derivative. 39 In addition, differentiation is regulated by a pathway involving the sterol regulatory element binding protein-1c (SREBP-1c, also known as adipocyte determination and differentiation factor-1, ADD-1), a pathway that in adipocytes is regulated by insulin. 40, 41 Given that individual adipocytes can also expand over a very large range as they store more TG, the net effect is that the capacity to store fat can increase seemingly without limit. Expansion of fat stores, especially if differentiation of new adipocytes is involved, requires new blood vessels. Angiogenesis in adipose tissue appears also to be regulated in part by factors produced within the tissue. Leptin has angiogenic properties, 42, 43 and adipocytes secrete matrix metaloproteinases that may be involved in vascular remodelling. 44 Expression of genes involved in angiogenesis is upregulated during weight gain in animals, 45, 46 and inhibition of angiogenesis reduces fat deposition in various obesity models in mice. 47 Situations of negative energy balance involve loss of adipocyte TG stores. While this involves shrinkage of adipocytes, there is now considerable evidence that apoptosis is also involved in the turnover of adipocytes. 48, 49 The subject of adipocyte apoptosis has been reviewed previously in this journal and we will not cover it in more detail here.
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Adipose tissue blood flow
Adipose tissue blood flow after an overnight fast is typically around 3 ml blood per 100 g tissue per minute, whereas in resting skeletal muscle the value is more like 1.5 ml blood per 100 g tissue per minute. 51 Skeletal muscle blood flow can increase many-fold (perhaps 20-fold) during exercise. Adipose tissue blood flow is also very labile. In some lean, healthy subjects subcutaneous abdominal blood flow increases several-fold (up to four-fold) in response to a meal 52-57 ( Figure 2 ). There are similar increases in thigh and forearm adipose tissue blood flow in response to feeding. 52, 58, 59 Adipose tissue blood flow also increases during exercise, 60, 61 although the increase is not particularly marked except during very prolonged exercise. Adipose tissue blood flow increases steadily during the night, presumably reflecting increasing duration of fasting.
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Extending an overnight fast (14 h) fast to 22 h causes no significant change in flow, 63 but more prolonged (72 h) fasting increases blood flow further (approximately 1.5-fold). 64 Thus, it appears that there is some minimum value for adipose tissue blood flow at rest in a late postprandial state: blood flow increases as fasting continues, or when a meal is eaten, or during exercise. In all these states, the increase in adipose tissue blood flow may be related to the Integrative physiology of human adipose tissue KN Frayn et al metabolic activity of the tissue. During fasting or during exercise, adipose tissue releases NEFA, and requires a supply of plasma albumin for transport of these NEFA into the circulation. After feeding, there is a need to increase substrate delivery for TG clearance. When adipose tissue blood flow was increased by infusion of adrenaline, TG extraction increased exactly in parallel with increased blood flow 65 ( Figure 3 ), implying that TG extraction is normally limited by substrate delivery. It must be pointed out that the peak in adipose tissue blood flow after eating is early, and does not correspond closely to the later peak in plasma TG concentration, so there may be some role for the increased postprandial blood flow that we do not yet understand. For instance, it might serve to deliver a signal, such as insulin, to initiate the postprandial increase in LPL activity. Regulation of adipose tissue blood flow has been studied extensively (reviewed by Frayn and Macdonald 66 ). In humans, adrenergic influences are predominant, with bmediated vasodilatation 67 and a2-mediated vasoconstriction. 68 These influences may explain the increased blood flow during fasting or exercise. Studies in patients with spinal cord lesions suggest that circulating catecholamines are more important in the exercise-induced increase in adipose tissue blood flow than sympathetic nerve activity. 69 The increase in blood flow following feeding has not been fully explained. Its time course parallels that of plasma insulin concentrations, 54 although insulin itself is not the local signal responsible. 56 The blood flow response to feeding is blocked by propranolol infusion 58 (completely in some depots, partially in others) suggesting that it is dependent upon sympathetic activation induced by postprandial hyperinsulinaemia. Again, therefore, the need for an integrated approach to studying adipose tissue function is evident. The global regulation of blood flow is probably modulated by locally produced factors including unbound NEFA, 70 adenosine, nitric oxide and prostaglandins. Adipocytes also express and secrete angiotensinogen and angiotensin-II, which may relate to vasomotor control. 71 
Innervation of white adipose tissue
One obvious signalling pathway relevant to regulation of net fat deposition would be via the autonomic nervous system. Both sympathetic (adrenergic) 21 ( Figure 4 ) and parasympathetic (cholinergic) 72 activation affect adipose tissue lipolysis.
There has been little histological work on the innervation of human adipose tissue, so the following information is based mainly on work in rats and hamsters. The similar effects of catecholamines and adrenoceptor agonists and antagonists on human and animal adipose tissue in vitro and in vivo provide a reasonable indication that the patterns of innervation seen in experimental animals also occur in human white adipose tissue.
It has been known for many years that white adipose tissue is innervated by the sympathetic nervous system (SNS). Integrative physiology of human adipose tissue KN Frayn et al
However, there has been some controversy as to whether these nerves only terminate on the blood vessels 73 or whether they also synapse with the adipocytes. 74 It has been suggested that there might be two pools of adipocytes, only one of which is innervated, 74 and electron microscopy suggests that only approximately 3% of adipocytes receive direct innervation. 75 If this were the case, it would not be surprising that some authors failed to observe innervation of adipocytes. However, some preliminary data show more extensive cellular innervation, with marked regional differences. 76 Histofluorescence and confocal microscopy were used to demonstrate catecholamine-containing nerves in direct contact with adipocytes, taken from epididymal, perirenal, mesenteric and inguinal regions of the rat. The highest level of innervation was observed in the mesenteric depot, and the lowest in the inguinal. Further evidence of direct innervation of adipocytes was provided by injection of fluorescent tracers into the sympathetic chain of hamsters, with the observation of rings of fluorescence around fat cells in both epididymal and inguinal regions. 77 The same authors showed that some of the innervation of these two regions arose from different parts of the sympathetic chain, providing the structural basis for selective activation of adipose tissue. 77 This possibility was confirmed by the demonstration of higher rates of noradrenaline turnover in epididymal compared to inguinal fat pads of hamsters acutely exposed to a reduced day length. The SNS innervation of white adipose tissue leads to the release of the neurotransmitter noradrenaline, and drugs that stimulate or antagonise adrenoceptors have the potential for directly affecting adipose tissue function. In addition, such drugs and the catecholamines, adrenaline and noradrenaline, have the potential to influence the blood flow through adipose tissue and other parts of the cardiovascular system and could thus indirectly affect adipose tissue function. Adrenergic receptors expressed within adipose tissue have been extensively studied. 78, 79 Obesity is associated with changes in adrenoceptor numbers and subtypes. 80 This suggests that the autonomic signals to adipose tissue are modulated in response to energy stores and adipocyte size. While receptor numbers are probably regulated over periods of days and weeks, changing local sympathetic activity is a more acute regulator of adipose tissue activity. Local noradrenaline spillover from a subcutaneous adipose tissue bed does not change significantly between the overnight fasted state (14 h fast) and 22 h fast. 81 In contrast, there is increased noradrenaline spillover from adipose tissue associated with (and possibly causing) increased local blood flow 60-120 min after eating and after 72 h fasting. 64, 82 In addition to acute effects on adipose tissue function, the SNS innervation appears to affect cell numbers. Denervation of retroperitoneal adipose tissue in rats increases fat pad weight. 83 Within 1 week of denervation there was proliferation of preadipocytes and after 1 month there was an increase in the numbers of mature adipocytes. Denervation did not affect glucose metabolism, nor LPL and HSL expression and activity. Denervation also increased fat pad weight in the hamster, even in conditions of reduced food intake produced by exposing the animals to a short day length. 84 Specific removal of the parasympathetic innervation has the opposite effects (see below).
As well as its effects on adipose tissue function, the sympathetic innervation of white adipose tissue appears to have an afferent component, which presumably sends signals to either the spinal cord or the brain. Injection of small amounts of leptin into perirenal adipose tissue in rats was associated with increased renal sympathetic efferent activity without altering plasma leptin concentration. 85 Studies on hamsters and rats have demonstrated direct neural connections between white adipose tissue and several different brain regions involved in the SNS regulation of the cardiovascular and other systems. 86 There was little difference between the species, and the areas of the brain involved were similar to those previously shown to be neurally connected to the adrenal medulla.
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Considerably less attention has been paid to parasympathetic innervation of adipose tissue, which historically was considered to be less important than sympathetic innervation (reviewed in Frayn and Macdonald 66 ). More recently this view has changed. Cholinergic stimuli affect lipolysis in vivo as determined by microdialysis: nicotinic receptor stimulation increases and muscarinic receptor stimulation decreases lipolysis in humans. 72 Newer studies in the rat show clearly parasympathetic innervation, which can be traced to origins in the brain stem. 88 When this vagal innervation was severed, fat pad anabolic processes (glucose and fatty acid uptake) were impaired and HSL activity increased. 88 The implication is of a dual innervation, the sympathetic controlling catabolic processes and the parasympathetic anabolic. 89 It is clear, therefore, that the autonomic innervation of white adipose tissue is of major importance in the regulation of tissue mass and function. It is less clear how this relates to the autonomic control of other physiological processes, or the extent to which acute activation or suppression of adipose tissue by the autonomic nervous system affects metabolic processes such as insulin sensitivity, peptide secretion or even lipolysis.
Site-specific properties of adipose tissue depots
Adipose tissue, like skeletal muscle, is distributed through the body in discrete depots. Although the different depots may assume different importance in various species, 90, 91 nevertheless there are homologous depots in all mammals. Some of these are small (eg the popliteal) and seem to have some primary function other than as a reserve of fat, others are larger and contribute more to fat storage and mobilisation. We have chosen in this review to concentrate on the similarities among adipose tissue depots rather than their Integrative physiology of human adipose tissue KN Frayn et al differences. For instance, NEFA release from one particular, relatively large depot, the subcutaneous anterior abdominal depot, correlates strongly with systemic plasma NEFA concentrations, 92 arguing for common control of lipolysis in all large depots. Similarly, when blood flow has been studied in various depots, there are qualitative similarities in the responses to nutrient ingestion. 58 Nevertheless, since the early clinical observations of Vague 93, 94 that upper-body obesity was associated with a much greater incidence of adverse consequences (largely related to insulin resistance and dyslipidaemia) than was lower-body obesity, much attention has been directed towards trying to understand the physiological differences between these sites. Much of this work has been carried out by preparing isolated adipocytes from biopsies from the various sites removed at surgery. [95] [96] [97] [98] In view of the complex integration of adipose tissue metabolism in vivo, stressed in this review, results from such in vitro observations must be interpreted with some caution. The general picture that emerges is, however, consistent: intra-abdominal 'visceral' adipocytes have the highest metabolic activity followed by upper-body subcutaneous adipocytes, and lowest response in lower-body adipocytes. 99 Metabolic activity here refers mainly to lipolysis: intra-abdominal adipocytes have the highest rates of lipolysis when stimulated with a b-adrenoceptor agonist, and lipolysis is least susceptible to suppression by insulin. Thus, it could be simplistically argued that upper-body adipocytes discharge fatty acids at a high rate, and interfere with insulin-sensitive glucose metabolism. Lower-body fat depots may be efficient at removing fat from the circulation and they are relatively resistant to loss during weight loss. 100 Their predominance in women may imply that these are long-term fat reserves to cover eventualities such as child-bearing and nurturing if food supply runs short. However, this view is necessarily simplistic. 101 To make one obvious point, continued high rates of lipolysis would lead to disappearance of the fat depot unless they were matched at some other time by high rates of fat deposition. Fat deposition is much less easily studied in vitro. Measurements of LPL activity in intra-abdominal adipose tissue show no consistent pattern relative to subcutaneous tissue, [102] [103] [104] [105] and measurements of fatty acid incorporation into TG in isolated adipocytes show a lower rate of TG synthesis in omental than subcutaneous tissue. 106 Such studies as have been performed in vivo lend general support to the picture. When subjects were given isotopically labelled fatty acids, and biopsies of different depots were taken at abdominal surgery 24 h later, 102 accumulation of label was most marked (per g TG) in the omental and retroperitoneal depots. This is in agreement with a high rate of lipid turnover. Microdialysis measurements show considerably greater lipolysis during exercise in subcutaneous abdominal fat than in gluteal (lower-body). 21 Whole-body physiological studies of fat mobilisation provide a clearer picture of the relative roles of lower and upper-body fat depots. Jensen and co-workers have studied lean people, and people with upper and lower-body obesity using depot-specific catheterisations and labelled fatty acid tracers. The contribution of the visceral fat depot was assessed by hepatic venous catheterisation. It was concluded that the upper-body subcutaneous adipose tissue provides the major proportion of the systemic NEFA, whereas the lower-body fat only provides a small proportion. 107, 108 The visceral adipose tissue depot provides little NEFA to the systemic circulation and even in women with upper-body obesity, the specific contribution to NEFA delivery to the liver from the visceral depot was small relative to upper-body subcutaneous fat. 108 Another view is that the relative importance of the different depots with regard to adverse effects may reflect differential expression of secreted peptides. There has been a large literature on this topic and we will refer to it in the appropriate section below. It should be noted, however, that for the one adipose tissue-derived peptide clearly shown to have physiological relevance in man, leptin, secretion is considerably greater from subcutaneous than from visceral fat depots.
109,110
Adipose tissue and peptide secretion Adipose tissue was first suggested to have endocrine functions by Siiteri, 111 who pointed to the tissue's ability to interconvert steroid hormones. More recently interest has moved to adipose tissue production and secretion of a wide range of proteins. Many of these are classical cytokines and others, including leptin, are structurally related to cytokines. This has led to the introduction of the term adipocytokines to describe this wide range of proteins produced by adipose tissue. The use of the term adipocytokine also highlights that several proteins produced by adipocytes may act locally as autocrine and paracrine factors rather than remote-acting endocrine factors. Before discussing adipose tissue production of adipocytokines and other endocrine factors, it is worth reiterating that adipose tissue characteristics often differ between species, between depots within an individual and even between cells in different parts of a depot. In addition, adipocytokine production may differ between adipocytes at different stages of their development, for example, preadipocytes producing less tumour necrosis factor (TNF) than mature cells.
Adipocytokines
Adipose tissue's endocrine function is now well established for some protein hormones, most notably leptin. The identification of leptin as an adipostatic hormone 112 transformed views of the tissue and of obesity. To summarise, leptin is a hormone that arises predominantly (495%) from adipose tissue (especially subcutaneous depots), and its secretion is under regulation by the size of the whole-body The clear regulation of leptin secretion by these factors that reflect whole-body energy status suggests that adipose tissue is capable of determining short-and long-term energy status and changing its endocrine activity accordingly. Leptin's actions are mostly beyond the scope of the article and the reader is referred to other reviews of this topic. 116, 117 In summary, leptin clearly has major effects reducing food intake in both rodents and man. In rodents (but possibly not in man) it stimulates the SNS to increase energy expenditure 118 and it may increase fatty acid oxidation in muscle. 119 Leptin is required for fertility; leptin deficiency (as seen in undernutrition or anorexia nervosa, or in people with leptin or leptin-receptor mutations) causes delayed sexual maturity and anovulation.
120-124
The recognition of leptin's important roles stimulated the search for other proteins secreted by adipose tissue and/or adipocytes. It appears that a large proportion of the genetic material expressed within adipose tissue encodes secretory proteins, but at present there is some uncertainty as to whether all the proteins secreted by adipose tissue or adipocytes in vitro are released into the systemic circulation. 125 Several proteins have been demonstrated to be secreted into the circulation by human subcutaneous abdominal tissue in vivo. This group includes interleukin-6 (IL-6) and soluble receptors for TNFa. 126 ,127 IL-6, which is structurally related to leptin, appears to act as a hormone. 128 For each of these secreted adipocytokines, it appears from whole-body extrapolations that obese subjects release more protein from their expanded adipose tissue mass into the general circulation. However, in regard to acute regulation, there is little evidence that IL-6 and soluble receptors for TNFa are regulated by food intake. 126, 127 Several other proteins are secreted by adipose tissue in vitro. This group includes TNFa, plasminogen activator inhibitor-1 and components of the renin-angiotensin system. 71, 129 It remains to be established which of these are secreted into the systemic circulation by adipose tissue. For example, although adipocytes secrete TNFa, and this cytokine can induce insulin resistance, 130 it may act more as a paracrine than as an endocrine factor. 126, 127 TNFa production is increased in obesity and does respond to insulin and other energy-balance signals 130 and has several effects on adipocytes including inducing apoptosis, 48 suggesting that it is one means by which adipocytokines respond to limit further adiposity. Recently, several additional proteins have been described that are secreted by adipose tissue in vitro, adiponectin, fasting-induced adipose factor (FIAF) and resistin: each appears to reach the systemic circulation from adipose tissue.
Adiponectin, secreted solely by adipose tissue, is the gene product of the most abundant gene transcript-1 (apM1), which is abundantly expressed in white adipose tissue. The protein has structural homology with collagen VIII, collagen X, complement C1q as well as with TNFa. 131 mRNA expression of adiponectin increases as preadipocytes differentiate and is reduced by TNF. 132 Adiponectin protein is abundant in human plasma, typically accounting for 0.01% of total plasma protein and circulating adiponectin concentrations are reduced in obesity. 133 These concentrations are further reduced in diabetes mellitus and/or in insulin resistance, 133 and in coronary artery disease including myocardial infarction. 134 Furthermore, administration of recombinant adiponectin reverses insulin resistance of glucose metabolism 135, 136 in part by increasing fatty acid oxidation and energy dissipation in skeletal muscle and in part by inhibiting hepatic glucose output. The diurnal profiles of adiponectin are relatively flat, 134 which suggest that adiponectin acts as an adipostat sensing either adipose tissue mass or the resulting insulin resistance. Adiponectin signalling from adipose tissue appears to preserve fat utilisation in muscle and promotes glucose utilisation. These two events may provide unified dysregulation of the metabolic abnormalities in the insulin resistance syndrome. Adiponectin may have a protective role in the vascular wall. 137, 138 It can accumulate within injured vascular walls 139 and can suppress TNFa-induced expression of adhesion molecules in vascular endothelial cells. 137 This action is on the postreceptor part of TNF signalling, although the 'adiponectin receptor ' has not yet been identified. Other actions of adiponectin include suppression of macrophage to foam-cell transformation in vitro, 131, 137 and inhibition of endothelial signalling through cAMP. In addition to its effects on the endothelium and vascular wall, adiponectin can downregulate haematopoeisis and the immune system. 140 FIAF is another factor that has recently been identified as a secreted product of white (and brown) adipose tissue. Other tissues, such as liver and lungs, appear to express the mRNA for this protein to a much lower extent than does adipose tissue. As its name implies, FIAF is strongly induced by fasting. The protein is a member of the fibrinogen/angiopoietin-like proteins. It is suggested that it is a sort of 'antileptin' being stimulated by undernutrition and responsible for orchestrating the metabolic adaptation to fasting. 141, 142 Resistin mRNA is found in white but not in brown adipose tissues, 143 and is found in high concentrations in the adipocyte cytoplasm. Resistin mRNA content varies from depot to depot, but, as the gene is PPARg-regulated, it is reduced by thiazolidinediones. 143 Circulating resistin concentrations increase with fat feeding and in obese animals. Antiresistin antibodies improve insulin resistance both 144 and it seems that resistin expression in mature human adipocytes or adipose tissue is very low or absent, [145] [146] [147] although one report suggests it is higher in abdominal than in lower-body adipose tissue. 148 It was initially suggested that resistin is secreted specifically by rodent adipocytes. However, the structurally related protein RELMa is secreted by the heart, liver and tongue, as well as adipose tissue and breast. RELMa is not found in preadipocytes. mRNA for RELMa is found only in the intestine. The receptor/s for resistin and RELMs is/are not yet understood. There is no consensus yet as to whether resistin secretion by adipose tissue is acutely regulated by food.
As reviewed earlier, some important proteins involved in local lipid metabolism are secreted in vivo, notably adipsin and ASP (reviewed above 15 ), and LPL. 149, 150 These proteins, which are not usually considered adipocytokines, probably function mostly within the adipose tissue to regulate lipid metabolism. Again, it appears from whole-body extrapolations that obese subjects release more of these proteins from their expanded adipose tissue mass into the general circulation. In regard to acute regulation, release of both LPL 149 Other endocrine functions Recent studies have confirmed that human adipose tissue in vivo does produce sex-steroids and glucocorticoids from precursors (eg androgens to oestrogens, cortisone to cortisol). 155, 156 However, whole-body extrapolations from individual depots suggest that while the sex-steroid conversion by adipose tissue is quantitatively important (10-20% of wholebody production), net glucocorticoid conversion is minor. 156 The conversion of sex steroids is increased by obesity and acutely regulated by insulin. Integrative physiology of human adipose tissue KN Frayn et al ultradian pattern 160, 161 and show pulsatility with a periodicity of less than 1 h. 162 For such leptin pulsation, it has been suggested that growth hormone pulsation is the pacemaker, 163 but this remains to be proven. Systemic plasma NEFA and glycerol concentrations show pulsatility, 164 as does lipolysis in omental adipose tissue in dogs, arguing for coordinated action of adipose tissue throughout the body. 165 Some of these apparent pulsations have a periodicity of only a few minutes, 165 which would suggest a neural pacemaker mechanism. This has recently been confirmed in dogs; b3-adrenoceptor blockade removes the oscillatory component with little effect on 'basal' plasma NEFA concentrations. 164 The existence of pulsatile behaviour emphasises the complexity of the integrative physiology within adipose tissue. Further studies in this area are needed.
Integration of adipose tissue fat stores in relation to energy balance
We can now summarise our understanding of how the pathways of fat deposition and fat mobilisation can be regulated in accordance with the integrated imbalance between whole-body energy intake and energy expenditure. The multiplicity of factors affecting adipose tissue metabolism, some generated in adipose tissue, seem to offer many opportunities for modulation of energy utilisation in other organs (for instance, adiponectin and resistin signalling to the liver and skeletal muscle). Effects on overall fat stores are less convincing in humans: possibly leptin becomes ineffective once a certain level of obesity is reached, confirming that leptin is essentially a 'starvation hormone' rather than one of abundance. Ultimately, it would seem that there must be some controlling signal originating outside adipose tissue that regulates net adipose tissue TG deposition. A role for the SNS in regulation of net fat stores would seem to be likely, especially with current understanding that the sympathetic system is not a coherent whole but different efferent branches can be activated independently. 166, 167 Such a system would have to involve the brain in sensing energy balance independently of the leptin system, which basically responds to TG storage although with 'fine tuning' by insulin. It is not immediately clear how this would operate. Alternatively insulin itself might be the signal. An excess of energy intake over energy expenditure will generally lead to an increase in glycogen stores, small elevation of (fasting) plasma glucose concentration and a rise in insulin. Insulin, as noted several times above, has a strong effect in stimulating net fat storage in adipocytes. This hypothesis does not, however, explain how fat accumulation would occur if someone were to over eat solely fat. This is clearly an unphysiological situation, but if it is mimicked acutely by intravenous infusion of a TG emulsion, producing no detectable increase in plasma insulin, there is a marked decrease in NEFA release from adipose tissue, reflecting a suppression of HSL activity. 168, 169 This experiment seems to imply that there is some signal that responds to increased nutrient availability to regulate net fat storage independently of insulin, and in this case presumably also independently of the SNS.
In conclusion, adipose tissue function can only be truly understood when studied in an integrated way ( Figure 5 ). There is much to be learned still about the regulation of TG storage in adipose tissue. Key questions for the future are (1) whether there is a single or multiple, signals from outside the tissue that regulate adipocyte fat storage pathways appropriately and, if so, what the nature of such a signal might be; and (2) whether indeed adipose tissue, through secretion of peptides and metabolites, regulates metabolic processes in other tissues to help to achieve appropriate fat balance. As our understanding of the integrative physiology of adipose tissue increases, we hope that these, and many other aspects of adipose tissue function, will be clarified.
